Inventor · disambiguated record
Jean-Pierre Mach
Also filed as: MACH JEAN-PIERRE
9 granted patents·7 pending applications·116 citations·filing 1989–2020
87Inventor score
Top patents by PatentIndex Score
16 records- 0187US5047507AMonoclonal antibodies with specificity affinity for human carcinoembryonic antigenRES CORP TECHNOLOGIES INC·Filed 1989·Granted Sep 10, 1991·79 cites·9 claims
- 0286US10815310B2Multispecific antigen binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-kappa domainsCENTRE NAT RECH SCIENT·Filed 2017·Granted Oct 27, 2020·4 cites·13 claims
- 0381US9631031B2Multispecific antigens binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-κ domainsKADOUCHE JEAN·Filed 2012·Granted Apr 25, 2017·4 cites·7 claims
- 0477US9809654B2Targeted CD1d moleculesROBERT BRUNO·Filed 2003·Granted Nov 7, 2017·9 cites·29 claims
- 0574US9603922B2Modulation of NKT cell activity with antigen-loaded CD1d moleculesDONDA ALENA·Filed 2008·Granted Mar 28, 2017·8 cites·18 claims
- 0669US11945879B2Multispecific antigens binding fragments and multispecific antibodiesCENTRE NAT RECH SCIENT·Filed 2020·Granted Apr 2, 2024·0 cites·3 claims
- 0767US12378325B2Multispecific antigens binding fragments and multspecific antibodiesKADOUCHE JEAN·Filed 2020·Granted Aug 5, 2025·0 cites·2 claims
- 0852US2004143094A1Multicomponent conjugates which bind to target molecules and stimulate T cell lysisFiled 2003·Application pending·0 cites
- 0951US7968103B2Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver componentsWESTPHAL OTTO·Filed 2004·Granted Jun 28, 2011·2 cites·17 claims
- 1047US2007237771A1Multicomponent conjugates which bind to target molecules and stimulate T cell lysisDONDA ALENA·Filed 2007·Application pending·0 cites
- 1145US5672513ACarcino-embryonic antigen derivatives lacking the carboxyl terminal endROCHE DIAGNOSTIC SYSTEMS INC·Filed 1994·Granted Sep 30, 1997·10 cites·3 claims
- 1245US2016184404A1Novel hemoglobin-derived peptide based pharmaceutical compositionsCLINIQUE LA PRAIRIE·Filed 2014·Application pending·0 cites
- 1342US2004068100A1Multicomponent conjugates which bind to target molecules and stimulate cell lysisFiled 2001·Application pending·0 cites
- 1441US2017312356A1MODULATION OF NKT CELL ACTIVITY WITH ANTIGEN-LOADED CD1d MOLECULESVACCINEX INC·Filed 2017·Application pending·0 cites
- 1538US2010105876A1Method for the oligomerisation of peptidesTERSKIKH ALEXEY·Filed 2002·Application pending·0 cites
- 1632US2006233808A1Peptabody for cancer treatmentDEPERTHES DAVID·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →